Literature DB >> 21243021

Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience.

R Rihani1, W Hayajneh, I Sultan, L Ghatasheh, F Abdel-Rahman, N Hussein, A Hussein, A Al-Zaben, M Sarhan, M Saad.   

Abstract

We retrospectively reviewed medical records of 39 hematopoietic SCT (HSCT) recipients who presented at our hospital between 1 October 2009 and 31 January 2010 with the 2009 H1N1 influenza infection. The median age at presentation was 13.8 years (range: 3.3-56.9), infections developed at a median of 585 days (range: 0-2316) post transplant, the majority (n=27, 69%) occurred in allogeneic HSCT recipients, 12 (31%) patients were on immunosuppressive therapy and 12 (31%) had GVHD. Lower airway disease was present in 8 patients (21%). In total, 15 patients (39%) were hospitalized with a median duration of 4.5 days (range: 3-27 days) and 3 (8%) required mechanical ventilation; 2 of whom died.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243021     DOI: 10.1038/bmt.2010.329

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 2.  Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Authors:  Christian Renaud; Angela P Campbell
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

3.  Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients.

Authors:  Su-Mi Choi; Alexandre A Boudreault; Hu Xie; Janet A Englund; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2011-03-03       Impact factor: 22.113

Review 4.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

5.  Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study.

Authors:  Maria Cecilia Dignani; Patricia Costantini; Claudia Salgueira; Rosana Jordán; Graciela Guerrini; Alejandra Valledor; Fabián Herrera; Andrea Nenna; Claudia Mora; Inés Roccia-Rossi; Daniel Stecher; Edith Carbone; Ana Laborde; Ernesto Efron; Javier Altclas; Aníbal Calmaggi; José Cozzi
Journal:  F1000Res       Date:  2014-09-12

Review 6.  Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing.

Authors:  Starling A Sim; Vivian K Y Leung; David Ritchie; Monica A Slavin; Sheena G Sullivan; Benjamin W Teh
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-09       Impact factor: 5.742

7.  Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.

Authors:  Futoshi Iioka; Ryuichi Sada; Yoshitomo Maesako; Fumihiko Nakamura; Hitoshi Ohno
Journal:  Int J Hematol       Date:  2012-07-08       Impact factor: 2.490

8.  Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany.

Authors:  Nicola Lehners; Steffen Geis; Christoph Eisenbach; Kai Neben; Paul Schnitzler
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.